Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 14
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00996372 | Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women | ||
NCT01103362 | A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder | ||
NCT00491829 | Flibanserin Versus Placebo in Premenopausal Women With HSDD | ||
NCT00360529 | 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder | ||
NCT00601367 | Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder | ||
NCT01057901 | Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America | ||
NCT00277914 | Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women | ||
NCT00441558 | A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD). | ||
NCT00360555 | Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder | ||
NCT01040208 | 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress | ||
NCT00996164 | Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder | ||
NCT01188603 | Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) | ||
NCT00360243 | 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA | ||
NCT04002661 | Hypoactive Sexual Desire Disorder in Males |